Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.36M | -2.75M | -4.13M | -6.20M | -8.32M |
| Total Depreciation and Amortization | 258.10K | 450.70K | 644.10K | 712.70K | 786.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.30K | 335.60K | 480.80K | 516.50K | 561.20K |
| Change in Net Operating Assets | 68.30K | 736.20K | 1.41M | 1.41M | 1.41M |
| Cash from Operations | -839.30K | -1.22M | -1.60M | -3.56M | -5.57M |
| Capital Expenditure | -- | -54.40K | -109.00K | -116.90K | -124.90K |
| Sale of Property, Plant, and Equipment | 55.10K | 55.10K | 55.10K | 27.50K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 55.10K | 700.00 | -53.90K | -89.40K | -124.90K |
| Total Debt Issued | 720.00K | 970.00K | 1.22M | 2.36M | 3.50M |
| Total Debt Repaid | -43.20K | -233.40K | -423.60K | -697.70K | -971.80K |
| Issuance of Common Stock | 3.13M | 2.55M | 1.97M | 2.18M | 2.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -192.20K | -234.40K | -276.60K | -447.90K | -619.20K |
| Cash from Financing | 2.39M | 2.02M | 1.63M | 2.23M | 2.85M |
| Foreign Exchange rate Adjustments | 13.50K | -1.10K | -15.80K | -9.10K | -2.10K |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 1.61M | 795.10K | -45.70K | -1.43M | -2.85M |
